Pharmaceutical company announces pause of COVID-19 antibody treatment trial

Eli Lilly paused its antibody treatment trial to investigate a potential safety concern. The treatment is similar to the one President Donald Trump received when diagnosed with COVID-19.

October 13, 2020

Examined